ArticleOncotarget2016

Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint.

Jiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.